HIV Annual Shot Clinical Trial: HIV is a dangerous infection that destroys the lives of the people. If HIV. Infection, it can cause a fatal disease of AIDS. To avoid HIV, people have to be pulled and in-time pills and injections. People who have a greater risk of HIV, they need to be treated. However, scientists have now given a gospel. In a new search clinical trial, a vaccine has proved to be effective. This vaccine has to pay only once a year.
BBC’s
Report According to This vaccine that saves HIV once can be applied once and can be useful for higher risk persons. Such people currently need to take pills or injections every second month to stop HIV. The new injection is proved to be effective in Lenacapavar Stage 1 Clinical trials. The research has shown that the intimopular injection is safe to prevent HIV’s infection and its presence in the body lasts at least 56 weeks. This can lead to HIV.
This study is published in a medical journal called ‘Limset’. In this research, 40 HIV-free people were given Lankopher Injection, which was injected in the muscles. This injection has no side effects or security problems. After 56 weeks the drug is being identified in his body. Currently, people can take pre-Exposure libraxis by taking every eight weeks and take pre-exposed libxis. These drugs can help reduce the risk of HIV. Prep tablets are very effective, but it can be difficult for some people to take them every day. According to the most recent statistics of 2023, about 39 million people are living with HIV, of which 65% of which live in the African region.